0001209191-20-059511.txt : 20201119
0001209191-20-059511.hdr.sgml : 20201119
20201119184249
ACCESSION NUMBER: 0001209191-20-059511
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200812
FILED AS OF DATE: 20201119
DATE AS OF CHANGE: 20201119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLARK IAN T
CENTRAL INDEX KEY: 0001336504
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 201329984
MAIL ADDRESS:
STREET 1: SOLAZYME, INC.
STREET 2: 225 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-12
0
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001336504
CLARK IAN T
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO
CA
94107
1
0
0
0
Stock Option (Right to Buy)
4.406
2020-08-12
4
A
0
209690
0.00
A
2030-08-11
Common Stock
209690
209690
D
Stock Option (Right to Buy)
19.00
2020-11-18
4
A
0
21520
0.00
A
2030-11-17
Common Stock
21520
21520
D
The shares subject to the option vest in a series of 36 successive equal monthly installments measured from August 12, 2020, subject to the
Reporting Person's continuous service through each applicable vesting date. The stock option is early exercisable.
The shares subject to the option vest in a series of 12 successive equal monthy installments measured from June 1, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.
/s/ John B. Moriarty, Jr., Attorney-in-Fact
2020-11-19